Expression of the L-type Calcium Channel with Two Different Beta Subunits and Its Modulation by Ro 40-5967
Overview
Affiliations
The smooth muscle alpha 1Cb subunit of the L-type calcium channel was expressed alone (CHO alpha 1 cell) or together with the skeletal beta 1 (CHO alpha 1 beta 1 cell) subunit or smooth muscle beta 3 (CHO alpha 1 beta 3 cell) subunit in Chinese hamster ovary (CHO) cells. The interaction of the expressed calcium channel with the non-dihydropyridine calcium channel blocker Ro 40-5967 was studied. Ro 40-5967 decreased isradipine binding by an apparent allosteric interaction and blocked the barium inward currents (IBa) in a voltage- and use-dependent manner in all cells. The steady-state inactivation curves were shifted to hyperpolarizing potentials in the presence of Ro 40-5967. The rate of channel inactivation was increased in CHO alpha 1 and CHO alpha 1 beta 3 cells. The shift in the steady-state inactivation curve and the increase in channel inactivation were less pronounced in CHO alpha 1 beta 1 cells than in the other cell lines. Low concentrations of Ro 40-5967 increased IBa by up to 198% in 33% of the CHO alpha 1 beta 1 cells. In addition, higher concentrations of Ro 40-5967 were required to inhibit IBa in 60% of the CHO alpha 1 beta 3 cells. These results suggest that the beta subunits modify the interaction of the non-dihydropyridine Ro 40-5967 with the expressed calcium channel alpha 1 subunit.
Beta subunits of voltage-gated calcium channels.
Dolphin A J Bioenerg Biomembr. 2004; 35(6):599-620.
PMID: 15000522 DOI: 10.1023/b:jobb.0000008026.37790.5a.
Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.
Liu J, Bijlenga P, Occhiodoro T, Fischer-Lougheed J, Bader C, Bernheim L Br J Pharmacol. 1999; 126(1):245-50.
PMID: 10051142 PMC: 1565812. DOI: 10.1038/sj.bjp.0702321.
Two stable cell lines for screening of calcium channel blockers.
Seisenberger C, Welling A, Schuster A, Hofmann F Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(6):662-9.
PMID: 9053739 DOI: 10.1007/BF00171326.